Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Explore which Low Cost Dividend ETF to invest in right now. We compare costs, yields, and diversification to help you decide efficiently.
27,336 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Investors ditching magnificent group are chasing a fresh AI-led cohort dubbed MANGOS, with Meta, Alphabet and NVIDIA ...
Oil prices slipped Friday as investors weighed the possibility of a U.S.-Iran peace deal that could reopen the Strait...
A Stage 2 cancer diagnosis accelerates critical financial planning for a 70-year-old couple with $1.8m, triggering im...
Analysts lift Intel targets on AI-driven demand, sending shares higher. The move underscores optimism about data cent...
Andre Cronje and two other Sonic Labs directors resign from the board, while the S token remains dramatically below i...
Investors are moving past SpaceX hype toward proven AI cash generators. This report explains why NVIDIA stands out as...
A Danish archaeological drill near Aarhus uncovers a 1,000-year-old massive textile factory, underscoring Viking indu...
A Vesta director recently sold roughly $203,000 worth of stock while the company’s shares have risen about 25% over t...
Goldman Sachs warns that leveraged stock bets are extremely focused on AI stocks, creating risk if AI sentiment shift...
The june jobs report came in well below forecasts, adding 57,000 payrolls and prompting a shift in Fed expectations a...
A SpaceX rumor about a full tech stack tied to Apple investor impact sparked a volatile session for AAPL, even as Elo...